Dr. Feinfield in Sherman Oaks, California

Name: Robert Feinfield, MD
Last name: Feinfield
Primary Specialty: Ophthalmologist
Business: Berg Feinfield Vision Correction
Address: 13320 Riverside Dr.
Address suite: Ste. 114
City: Sherman Oaks
State: California
Zip Code: 91423
Country: US
Consulting Fees: -1$
Has Sponsored Offer : No
Special Offers: 
Offer #1: Galderma Offer
Special Offer Treatments: All treatments
End Time: 12/31/2023
Detail: Sign up for Aspire Galderma Rewards prior to your appointment to receive $20 off on each treatment listed below: Dysport®, Restylane® family, Sculptra® Aesthetic.
Clinical Privileges: 
  • San Gabriel Valley Medical Center
Postdoc Training: 
  • Residency: LSU/Ochsner Eye Center in New Orleans

Robert Feinfield, MD

Board Certification: 
Robert Evan Feinfield (ABMSUID -30623)

Viewed: 8/27/2008
Day of birth: 10/10/1954

Status: Alive
Certification: American Board of Ophthalmology
Ophthalmology – General

Status: Certified Active Lifetime Initial Certification 5/5/1991 –
Education: 1981 MD (Doctor of Medicine)
Location: PrivateEncino, CA 91436-3110 (United States)

GPS coordinates on map: 34.1463,-118.4290009

Primary location: 
Location name: Sherman Oaks
State: CA
Country: US
Map point: 34.1463,-118.4290009
Treatments: 
  • Botox
  • Juvederm
  • LASIK

RealSelf Info

Profile views: 792
Star rating: 2.0473720558371
Offer count: 1
Profile created: Nov 18, 2007
Profile modified: Oct 2, 2019
Profile promotion: No
Profile inactive: No
Premier status: Free
Tier: Free-Claimed
RealCare Promise: No
Directory link: Board Certified Ophthalmologist
RealSelf’s PRO: No
Doctor Designation Start Time: Nov 1, 2011
Doctor Designation End Time: Jan 1, 2033

Locations

  • Sherman Oaks, CA, US. GPS coordinates: 34.1463,-118.4290009

Special Offers

Heading
Start Time / End Time
Detail
Treatments

Galderma Offer
Nov 1, 2019 /
Dec 31, 2023
Sign up for Aspire Galderma Rewards prior to your appointment to receive $20 off on each treatment listed below: Dysport®, Restylane® family, Sculptra® Aesthetic.
Specific treatments

Last updated on 12/19/2023